Gletmet-PG1 Tablet PR
Marketer
Kaymed Pharmaceuticals Pvt. Ltd.
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Gletmet-PG1 Tablet PR
DiaBeta-CP1 tablets are a dual-action medication designed to manage blood glucose. This medication complements a healthy diet and exercise regimen to enhance blood sugar regulation in adult patients with type 2 diabetes. It facilitates efficient insulin use, resulting in reduced blood sugar. DiaBeta-CP1 should be administered as prescribed by your physician, adhering to the recommended dosage and duration. To minimize digestive discomfort, take it with food. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. An overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood sugar monitoring is crucial during treatment. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor of any existing kidney, liver, or heart conditions. Pregnant or lactating women should consult their physician before use. Kidney function tests will be conducted before treatment begins. Limit alcohol consumption while taking this medicine to reduce the likelihood of adverse reactions.
Primary Ingredients of Gletmet-PG1 Tablet PR
No information provided. Please provide the text you wish me to rephrase.
Uses of Gletmet-PG1 Tablet PR
Managing type 2 diabetes
Major Benefits of Gletmet-PG1 Tablet PR:
Follow your physician's instructions or consult the product labeling for usage guidance. Administer Gletmet-PG1 Tablet PR with a meal.
Common Side effects of Gletmet-PG1 Tablet PR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Gletmet-PG1 Tablet PR:
Follow your physician's instructions or consult the product labeling for usage guidance. Administer Gletmet-PG1 Tablet PR with meals.
How Gletmet-PG1 Tablet PR works:
Gletmet-PG1 Tablet PR combines the actions of three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. These medications employ diverse methods to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity within the body.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Gletmet-PG1 Tablet PR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Gletmet-PG1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Gletmet-PG1 Tablet PR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Gletmet-PG1 Tablet PR cautiously, potentially requiring a modified dosage. Physician consultation is advised. Gletmet-PG1 Tablet PR is contraindicated in patients with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should exercise caution when using Gletmet-PG1 Tablet PR, potentially requiring a modified dosage. Physician consultation is advised. Gletmet-PG1 Tablet PR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Gletmet-PG1 Tablet PR :
Should you forget a Gletmet-PG1 Tablet PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gletmet-PG1 Tablet PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |

